Treatment of antigen-induced arthritis in rabbits with dysprosium-165-ferric hydroxide macroaggregates

J Orthop Res. 1989;7(1):50-60. doi: 10.1002/jor.1100070108.

Abstract

Dysprosium-165-ferric hydroxide macroaggregates (165Dy-FHMA) was used as an agent of radiation synovectomy in an antigen-induced arthritis model in New Zealand white rabbits. Animals were killed up to 6 months after treatment. 165Dy-FHMA was found to have a potent but temporary antiinflammatory effect on synovium for up to 3 months after treatment. Treated knees also showed significant preservation of articular cartilage architecture and proteoglycan content compared with untreated controls, but only during the first 3 months after treatment. In animals killed 3 and 6 months after treatment there were only minimal differences between the treated and untreated knees, indicating that the antiinflammatory effects on synovial tissue and articular cartilage preservation were not sustained.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens
  • Arthritis / radiotherapy*
  • Arthritis, Experimental / diagnostic imaging
  • Arthritis, Experimental / pathology
  • Arthritis, Experimental / radiotherapy*
  • Brachytherapy*
  • Cartilage, Articular / pathology
  • Drug Carriers
  • Dysprosium / administration & dosage
  • Dysprosium / therapeutic use*
  • Ferric Compounds
  • Fibrosis
  • Hyperplasia
  • Knee Joint / diagnostic imaging
  • Ovalbumin
  • Particle Size
  • Rabbits
  • Radiography
  • Radioisotopes / administration & dosage
  • Radioisotopes / therapeutic use*
  • Synovial Membrane / pathology

Substances

  • Antigens
  • Drug Carriers
  • Ferric Compounds
  • Radioisotopes
  • Dysprosium
  • ferric hydroxide
  • Ovalbumin